Key result
A steroid-eluting coronary venous lead for biventricular pacing maintained satisfactory pacing thresholds, impedance, and R wave amplitude up to 4 months after implantation.
Why the study?
Does a steroid-eluting coronary venous lead provide stable electrical parameters in patients with heart failure undergoing biventricular pacing?
RCT (n=58)
Does a steroid-eluting coronary venous lead provide stable electrical parameters in patients with heart failure undergoing biventricular pacing?
A steroid-eluting coronary venous lead for left ventricular pacing demonstrates stable and satisfactory electrical parameters up to 4 months post-implantation.
Answers are grounded in this paper and cite their sources.
Supports adoption of steroid-eluting LV leads in CRT; extends randomized evidence for short-term stability in heart failure.
The Ventak CHF/CONTAK CD Biventricular Pacing Study is a prospective randomized trial to examine the safety and efficacy of biventricular (BV) pacing in patients with standard indications for an ICD, symptomatic heart failure, a LVEF < or = 0.35, and a QRS > or = 120 ms. Patients underwent implantation of a BV pacing and sensing system with backup defibrillation capability, which includes a steroid-eluting coronary venous lead that is advanced into the coronary venous vasculature by over-the-wire techniques. LV pacing threshold, BV impedance, and BV R wave amplitude were measured in 58 consecutive patients. Using a percutaneous over-the-wire insertion technique, steroid-eluting coronary venous leads were associated with satisfactory mean LV pacing threshold, BV impedance, and BV R wave amplitude acutely up to 4 months after implantation. Pacing threshold stabilized 2 weeks after lead implantation and sensing threshold remained stable from the time of implant.
No takes yet. Share an insight, caveat, or question.
Achtelik et al. (2000) conducted an RCT in Symptomatic heart failure (n=58). Biventricular pacing system with a steroid-eluting coronary venous lead was evaluated on LV pacing threshold, BV impedance, and BV R wave amplitude. A steroid-eluting coronary venous lead for biventricular pacing maintained satisfactory pacing thresholds, impedance, and R wave amplitude up to 4 months after implantation.
Synapse has enriched 10 related papers. Consider them for comparative context: